|Bid||3,139.00 x 1400|
|Ask||3,146.55 x 800|
|Day's Range||3,101.52 - 3,172.51|
|52 Week Range||1,626.03 - 3,344.29|
|Beta (5Y Monthly)||1.33|
|PE Ratio (TTM)||120.91|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Today, AWS announces the general availability of AWS Wavelength in Boston and the San Francisco Bay Area.
Today, Amazon Web Services, Inc. (AWS), an Amazon.com company (NASDAQ: AMZN), announced that Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering a new class of messenger RNA (mRNA) medicines, has selected AWS as its preferred cloud provider, as well as its standard for analytics and machine learning workloads. Leveraging its mRNA platform and manufacturing facility with the AWS-powered research engine, Moderna delivered the first clinical batch of its vaccine candidate (mRNA-1273) against COVID-19 to the NIH for the Phase 1 trial 42 days after the initial sequencing of the virus. By building and scaling its operations on the world’s leading cloud, Moderna is able to quickly design research experiments and uncover new insights, automate its laboratory and manufacturing processes to enhance its drug discovery pipeline, and more easily comply with applicable laws and regulations during production and testing of vaccine and therapeutic candidates.
Amazon.com, Inc. (NASDAQ: AMZN) today announced plans to launch a new, state-of-the-art Amazon fulfillment center in Temple Terrace, Florida. The new fulfillment center, which is anticipated to launch in 2021, will create 750 new, full-time jobs with industry leading pay and comprehensive benefits starting on day one. Amazon currently operates seven fulfillment and sortation centers in the state in Jacksonville, Davenport, Orlando, Miami, Ruskin, and Lakeland.